{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T14:43:58Z","timestamp":1770821038226,"version":"3.50.1"},"reference-count":152,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,2,15]],"date-time":"2016-02-15T00:00:00Z","timestamp":1455494400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s00535-016-1166-4","type":"journal-article","created":{"date-parts":[[2016,2,15]],"date-time":"2016-02-15T15:41:01Z","timestamp":1455550861000},"page":"177-194","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":119,"title":["Evidence-based clinical practice guidelines for peptic ulcer disease 2015"],"prefix":"10.1007","volume":"51","author":[{"given":"Kiichi","family":"Satoh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junji","family":"Yoshino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taiji","family":"Akamatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyuki","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mototsugu","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoari","family":"Kamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshimi","family":"Chiba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachiyo","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Mizokami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunari","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Choitsu","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyuki","family":"Hiraishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masao","family":"Ichinose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomi","family":"Uemura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidemi","family":"Goto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Joh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroto","family":"Miwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Sugano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tooru","family":"Shimosegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,2,15]]},"reference":[{"key":"1166_CR1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s00535-014-1016-1","volume":"50","author":"M Yoshida","year":"2015","unstructured":"Yoshida M, Kinoshita Y, Watanabe M, et al. JSGE clinical practice guideline 2014: standards, methods, and process of developing guidelines. J Gastroenterol. 2015;50:4\u201310.","journal-title":"J Gastroenterol"},{"key":"1166_CR2","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1001\/jama.1990.03450040090037","volume":"264","author":"HS Sachs","year":"1990","unstructured":"Sachs HS, Chalmers TC, Blum AL, et al. Endoscopic hemostasis: an effective therapy for bleeding peptic ulcers. JAMA. 1990;264:494\u20139.","journal-title":"JAMA"},{"key":"1166_CR3","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.gie.2008.05.031","volume":"69","author":"AN Barkun","year":"2009","unstructured":"Barkun AN, Martel M, Toubouti Y, et al. Endoscopic hemostasis in peptic ulcer bleeding for patients with high-risk lesions: a series of meta-analysis. Gastrointest Endosc. 2009;69:786\u201399.","journal-title":"Gastrointest Endosc"},{"key":"1166_CR4","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1053\/gast.2002.34782","volume":"123","author":"D Jensen","year":"2002","unstructured":"Jensen D, Kovacs T, Jutabha R, et al. Randomized trial of medical or endoscopic therapy to prevent recurrent ulcer hemorrhage in patients with adherent clots. Gastroenterology. 2002;123:407\u201313.","journal-title":"Gastroenterology"},{"key":"1166_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1067\/mge.2002.125365","volume":"56","author":"B Bleau","year":"2002","unstructured":"Bleau B, Gostout C, Sherman K, et al. Recurrent bleeding from peptic ulcer associated with adherent clot: a randomized study comparing endoscopic treatment with medical therapy. Gastrointest Endosc. 2002;56:1\u20136.","journal-title":"Gastrointest Endosc"},{"key":"1166_CR6","doi-asserted-by":"crossref","first-page":"237","DOI":"10.7326\/0003-4819-139-4-200308190-00005","volume":"139","author":"JJ Sung","year":"2003","unstructured":"Sung JJ, Chan F, Lau J, et al. The effect of endoscopic therapy in patients receiving omeprazole for bleeding omeprazole for bleeding ulcers with nonbleeding visible vessels or adherent clots: a randomized clots: a randomized comparison. Ann Intern Med. 2003;139:237\u201343.","journal-title":"Ann Intern Med"},{"key":"1166_CR7","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1440-1746.2009.06129.x","volume":"25","author":"KK Tsoi","year":"2010","unstructured":"Tsoi KK, Chan HC, Chiu PW, et al. Second-look endoscopy with thermal coagulation or injections for peptic ulcer bleeding: a meta-analysis. J Gastroenterol Hepatol. 2010;25:8\u201313.","journal-title":"J Gastroenterol Hepatol"},{"key":"1166_CR8","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1111\/j.1572-0241.2008.02070.x","volume":"103","author":"BJ Elmunzer","year":"2008","unstructured":"Elmunzer BJ, Young SD, Inadomi JM, et al. Systematic review of the predictors of recurrent hemorrhage after endoscopic hemostatic therapy for bleeding peptic ulcers. Am J Gastroenterol. 2008;103:2625\u201332.","journal-title":"Am J Gastroenterol"},{"key":"1166_CR9","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-2036.2005.02546.x","volume":"22","author":"GI Leontiadis","year":"2005","unstructured":"Leontiadis GI, Sharma VK, Howden CW, et al. Systematic review and meta-analysis: proton-pump inhibitor treatment for ulcer bleeding reduces transfusion requirements and hospital stay-results from the Cochrane Collaboration. Aliment Pharmacol Ther. 2005;22:169\u201374.","journal-title":"Aliment Pharmacol Ther"},{"key":"1166_CR10","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1046\/j.1365-2036.2000.00822.x","volume":"14","author":"NM Selby","year":"2000","unstructured":"Selby NM, Kubba AK, Hawkey CJ, et al. Acid suppression in peptic ulcer haemorrhage: a \u2018meta-analysis\u2019. Aliment Pharmacol Ther. 2000;14:1119\u201326.","journal-title":"Aliment Pharmacol Ther"},{"key":"1166_CR11","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1572-0241.2006.00399.x","volume":"101","author":"HJ Lin","year":"2006","unstructured":"Lin HJ, Lo WC, Cheng YC, et al. Role of intravenous omeprazole in patients with high-risk peptic ulcer bleeding after successful endoscopic epinephrine injection: a prospective randomized comparative trial. Am J Gastroenterol. 2006;101:500\u20135.","journal-title":"Am J Gastroenterol"},{"key":"1166_CR12","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1136\/pgmj.60.704.400","volume":"60","author":"DL Carr-Locke","year":"1984","unstructured":"Carr-Locke DL, Taverner D, Wicks AC. Cimetidine therapy dose not prevent rebleeding from peptic ulceration. Postgrad Med J. 1984;60:400\u20133.","journal-title":"Postgrad Med J"},{"key":"1166_CR13","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-230X-6-2","volume":"6","author":"M Khoshbaten","year":"2006","unstructured":"Khoshbaten M, Fattahi E, Naderi N, et al. A comparison of oral omeprazole and intravenous cimetidine in reducing complications of duodenal peptic ulcer. BMC Gastroenterol. 2006;6:2.","journal-title":"BMC Gastroenterol"},{"key":"1166_CR14","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1443-1661.2011.01176.x","volume":"24","author":"T Sakurada","year":"2012","unstructured":"Sakurada T, Kawashima J, Ariyama S, et al. Comparison of adjuvant therapies by an H2-receptor antagonist and a proton pump inhibitor after endoscopic treatment in hemostatic management of bleeding gastroduodenal ulcers. Dig Endosc. 2012;24:93\u20139.","journal-title":"Dig Endosc"},{"key":"1166_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-152-1-201001050-00179","volume":"152","author":"JJY Sung","year":"2010","unstructured":"Sung JJY, Lau JYW, Ching JYL, et al. Continuation of low-dose aspirin therapy in peptic ulcer bleeding: a randomized trial. Ann Intern Med. 2010;152:1\u20139.","journal-title":"Ann Intern Med"},{"key":"1166_CR16","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1136\/gut.35.4.464","volume":"35","author":"CP Choudari","year":"1994","unstructured":"Choudari CP, Rajgopal C, Palmer KR. Acute gastrointestinal haemorrhage in anticoagulated patients: diagnoses and response to endoscopic treatment. Gut. 1994;35:464\u20136.","journal-title":"Gut"},{"key":"1166_CR17","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1365-2036.2004.01898.x","volume":"19","author":"JP Gisbert","year":"2004","unstructured":"Gisbert JP, Khorrami S, Carballo F, et al. Meta-analysis: Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy for the prevention of recurrent bleeding from peptic ulcer. Aliment Pharmacol Ther. 2004;19:617\u201329.","journal-title":"Aliment Pharmacol Ther"},{"key":"1166_CR18","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1046\/j.1365-2036.2001.01134.x","volume":"15","author":"KV Sharma","year":"2001","unstructured":"Sharma KV, Sahai AV, Corder FA, et al. Helicobacter pylori eradication is superior to ulcer healing with or without maintenance therapy to prevent further ulcer haemorrhage. Aliment Pharmacol Ther. 2001;15:1939\u201347.","journal-title":"Aliment Pharmacol Ther"},{"key":"1166_CR19","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1111\/j.1572-0241.1998.00333.x","volume":"93","author":"G Treiber","year":"1998","unstructured":"Treiber G, Lambert JR. The impact of Helicobacter pylori eradication on peptic ulcer healing. Am J Gastroenterol. 1998;93:1080\u20134.","journal-title":"Am J Gastroenterol"},{"key":"1166_CR20","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1111\/j.1572-0241.2004.40014.x","volume":"99","author":"AC Ford","year":"2004","unstructured":"Ford AC, Delaney BC, Forman D, et al. Eradication therapy in Helicobacter pylori positive peptic ulcer disease: systematic review and economic analysis. Am J Gastroenterol. 2004;99:1833\u201355.","journal-title":"Am J Gastroenterol"},{"key":"1166_CR21","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1056\/NEJM199501193320302","volume":"332","author":"JJ Sung","year":"1995","unstructured":"Sung JJ, Chung SC, Ling TK, et al. Antibacterial treatment of gastric ulcers associated with Helicobacter pylori. N Engl J Med. 1995;332:139\u201342.","journal-title":"N Engl J Med"},{"key":"1166_CR22","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1046\/j.1365-2036.1999.00535.x","volume":"13","author":"P Malfertheiner","year":"1999","unstructured":"Malfertheiner P, Bayerdorffer E, Diete U, et al. The GU-MACH study: the effect of 1-week omeprazole triple therapy on Helicobacter pylori infection in patients with gastric ulcer. Aliment Pharmacol Ther. 1999;13:703\u201312.","journal-title":"Aliment Pharmacol Ther"},{"key":"1166_CR23","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1046\/j.1365-2036.2003.01402.x","volume":"17","author":"K Higuchi","year":"2003","unstructured":"Higuchi K, Fujiwara Y, Tominaga K, et al. Is eradication sufficient to heal gastric ulcers in patients infected with Helicobacter pylori? A randomized, controlled, prospective study. Aliment Pharmacol Ther. 2003;17:111\u20137.","journal-title":"Aliment Pharmacol Ther"},{"key":"1166_CR24","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1007\/s00535-007-2076-2","volume":"42","author":"A Terano","year":"2007","unstructured":"Terano A, Arakawa T, Sugiyama T, et al. Rebamipide, a gastro-protective and anti-inflammatory drug, promotes gastric ulcer healing following eradication therapy for Helicobacter pylori in a Japanese population: a randomized, double-blind, placebo-controlled trial. J Gastroenterol. 2007;42:690\u20133.","journal-title":"J Gastroenterol"},{"key":"1166_CR25","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1111\/j.1365-2036.2010.04250.x","volume":"31","author":"H Hiraishi","year":"2010","unstructured":"Hiraishi H, Haruma K, Miwa H, et al. Clinical trial: irsogladine maleate, a mucosal protective drug, accelerates gastric ulcer healing after treatment for eradication of Helicobacter pylori infection\u2014the results of a multicentre, double-blind, randomized clinical trial (IMPACT study). Aliment Pharmacol Ther. 2010;31:824\u201333.","journal-title":"Aliment Pharmacol Ther"},{"key":"1166_CR26","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/j.1365-2036.2005.02418.x","volume":"21","author":"JP Gisbert","year":"2005","unstructured":"Gisbert JP, Pajares JM. Systematic review and meta-analysis: is 1-week proton pump inhibitor-based triple therapy sufficient to heal peptic ulcer? Aliment Pharmacol Ther. 2005;21:795\u2013804.","journal-title":"Aliment Pharmacol Ther"},{"key":"1166_CR27","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3164\/jcbn.10-10","volume":"47","author":"M Sasaki","year":"2010","unstructured":"Sasaki M, Ogasawara N, Utsumi K, et al. Changes in 12-year first-line eradication rate of Helicobacter pylori based on triple therapy with proton pump inhibitor, amoxicillin, clarithromycin. J Clin Biochem Nutr. 2010;47:53\u20138.","journal-title":"J Clin Biochem Nutr"},{"key":"1166_CR28","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1136\/gutjnl-2012-302084","volume":"61","author":"P Malfertheiner","year":"2012","unstructured":"Malfertheiner P, Megraud F, O\u2019Morain CA, et al. Management of Helicobacter pylori infection\u2014the Maastricht IV\/Florence Consensus Report. Gut. 2012;61:646\u201364.","journal-title":"Gut"},{"key":"1166_CR29","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1046\/j.1523-5378.2001.00037.x","volume":"6","author":"M Asaka","year":"2001","unstructured":"Asaka M, Sugiyama T, Kato M, et al. A multicenter, double-blind study on triple therapy with lansoprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients. Helicobacter. 2001;6:254\u201361.","journal-title":"Helicobacter"},{"key":"1166_CR30","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/j.1365-2036.2007.03298.x","volume":"25","author":"H Kuwayama","year":"2007","unstructured":"Kuwayama H, Asaka K, Sugiyama T, et al. Rabeprazole-based eradication therapy for Helicobacter pylori: a large-scale study in Japan. Aliment Pharmacol Ther. 2007;25:1105\u201313.","journal-title":"Aliment Pharmacol Ther"},{"key":"1166_CR31","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2165\/00044011-200626070-00002","volume":"26","author":"K Higuchi","year":"2006","unstructured":"Higuchi K, Maekawa T, Nakagawa K, et al. Efficacy and safety of Helicobacter pylori eradication therapy with omeprazole, amoxicillin and high- and low-dose clarithromycin in Japanese patients a randomized, double-blind, multicentre study. Clin Drug Invest. 2006;26:403\u201314.","journal-title":"Clin Drug Invest"},{"key":"1166_CR32","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1046\/j.1365-2036.2000.00911.x","volume":"14","author":"S Veldhuyzen Van Zanten","year":"2000","unstructured":"Veldhuyzen Van Zanten S, Lauritsen K, Delchier JC, et al. One-week triple therapy with esomeprazole provides effective eradication of Helicobacter pylori in duodenal ulcer disease. Aliment Pharmacol Ther. 2000;14:1605\u201311.","journal-title":"Aliment Pharmacol Ther"},{"key":"1166_CR33","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1365-2036.2008.03807.x","volume":"28","author":"A Villoria","year":"2008","unstructured":"Villoria A, Garcia P, Calvet X, et al. Meta-analysis: high-dose proton pump inhibitors vs. standard dose in triple therapy for Helicobacter pylori eradication. Aliment Pharmacol Ther. 2008;28:868\u201377.","journal-title":"Aliment Pharmacol Ther"},{"key":"1166_CR34","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1365-2036.2012.05211.x","volume":"36","author":"AG McNicoll","year":"2012","unstructured":"McNicoll AG, Linares PM, Nyssen OP, et al. Meta-analysis: esomeprazole or rabeprazole vs. first-generation pump inhibitors in the treatment of Helicobacter pylori infection. Aliment Pharmacol Ther. 2012;36:414\u201325.","journal-title":"Aliment Pharmacol Ther"},{"key":"1166_CR35","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-2710.2008.00969.x","volume":"34","author":"JL Tong","year":"2009","unstructured":"Tong JL, Ran ZH, Shen J, et al. Sequential therapy vs. standard triple therapies for Helicobacter pylori infection: a meta-analysis. J Clin Pharm Ther. 2009;34:41\u201353.","journal-title":"J Clin Pharm Ther"},{"key":"1166_CR36","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1523-5378.2009.00671.x","volume":"14","author":"AS Essa","year":"2009","unstructured":"Essa AS, Kramaer JR, Graham DY, et al. Meta-analysis: four-drug, three-antibiotic, non-bismuth containing \u201cconcomitant therapy\u201d vs. triple therapy for Helicobacter pylori eradication. Helicobacter. 2009;14:109\u201318.","journal-title":"Helicobacter"},{"issue":"Suppl 1","key":"1166_CR37","first-page":"79","volume":"19","author":"K Murakami","year":"2014","unstructured":"Murakami K, Sakurai Y, Shiino M, et al. A newly developed potassium-competitive acid blocker, vonoprazan vs. lansoprazole in first-line triple therapy with amoxicillin and clarithromycin for H. pylori eradication-phase 3, double blind study. Helicobacter. 2014;19(Suppl 1):79.","journal-title":"Helicobacter"},{"key":"1166_CR38","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00508-010-1404-3","volume":"122","author":"Y Li","year":"2010","unstructured":"Li Y, Huang X, Yao L, et al. Advantages of Moxifloxacin and Levofloxacin-based triple therapy for second-line treatments of persistent Helicobacter pylori infection: a meta analysis. Wien Klin Wochenschr. 2010;122:413\u201322.","journal-title":"Wien Klin Wochenschr"},{"key":"1166_CR39","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1523-5378.2011.00826.x","volume":"16","author":"C Wu","year":"2011","unstructured":"Wu C, Chen X, Liu J, et al. Moxifloxacin-containing triple therapy versus bismuth-containing quadruple therapy for second-line treatment of Helicobacter pylori infection: a meta-analysis. Helicobacter. 2011;16:131\u20138.","journal-title":"Helicobacter"},{"key":"1166_CR40","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1007\/s00535-012-0731-8","volume":"48","author":"K Murakami","year":"2013","unstructured":"Murakami K, Furuta T, Ando T, et al. Multi-center randomized controlled study to establish the standard third-line regimen for Helicobacter pylori eradication in Japan. J Gastroenterol. 2013;48:1128\u201335.","journal-title":"J Gastroenterol"},{"key":"1166_CR41","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.1994.03520010077036","volume":"272","author":"NIH consensus Development Panel Helicobacter pylori in Peptic","year":"1994","unstructured":"NIH consensus Development Panel Helicobacter pylori in Peptic. Ulcer Disease: Helicobacter pylori in peptic ulcer disease. JAMA. 1994;272:65\u20139.","journal-title":"JAMA"},{"key":"1166_CR42","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/0140-6736(91)93316-2","volume":"337","author":"R Fiocca","year":"1991","unstructured":"Fiocca R, Solcia E, Santoro B. Duodenal ulcer relapse after eradication of Helicobacter pylori. Lancet. 1991;337:1614.","journal-title":"Lancet"},{"key":"1166_CR43","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00000658-200002000-00001","volume":"231","author":"EK Ng","year":"2000","unstructured":"Ng EK, Lam YH, Sung JJ, et al. Eradication of Helicobacter pylori prevents recurrence of ulcer after simple closure of duodenal ulcer perforation: randomized controlled trail. Ann Surg. 2000;231:153\u20138.","journal-title":"Ann Surg"},{"key":"1166_CR44","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/00042737-199604000-00011","volume":"8","author":"E Bayerd\u00f6rffer","year":"1996","unstructured":"Bayerd\u00f6rffer E, Miehlke S, Lehn N, et al. Cure of gastric ulcer disease after cure of Helicobacter pylori infection: German Gastric Ulcer Study. Eur J Gastroenterol Hepatol. 1996;8:343\u20139.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1166_CR45","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1053\/gast.1997.v113.pm9322501","volume":"113","author":"RW Hulst Van der","year":"1997","unstructured":"Van der Hulst RW, Rauws EA, Koycu B, et al. Prevention of ulcer recurrence after eradication of Helicobacter pylori: a prospective long-term follow-up study. Gastroenterology. 1997;113:1082\u20136.","journal-title":"Gastroenterology"},{"key":"1166_CR46","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s005350300061","volume":"38","author":"M Asaka","year":"2003","unstructured":"Asaka M, Kato M, Sugiyama T, et al. Follow-up survey of a large-scale Multicenter, double -blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients. J Gastroenterol. 2003;38:339\u201347.","journal-title":"J Gastroenterol"},{"key":"1166_CR47","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1083-4389.2004.00194.x","volume":"9","author":"H Miwa","year":"2004","unstructured":"Miwa H, Sakaki N, Sugano K, et al. Recurrent peptic ulcers in patients following successful Helicobacter pylori eradication: a multicenter study of 4940 patients. Helicobacter. 2004;9:9\u201316.","journal-title":"Helicobacter"},{"key":"1166_CR48","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1007\/BF02088227","volume":"41","author":"F Mario Di","year":"1996","unstructured":"Di Mario F, Battaglia G, Leandro G, et al. Short-term treatment of gastric ulcer: a meta-analytical evaluation of blind trials. Dig Dis Sci. 1996;41:1108\u201331.","journal-title":"Dig Dis Sci"},{"key":"1166_CR49","first-page":"467","volume":"7","author":"S Eriksson","year":"1995","unstructured":"Eriksson S, Langstrom G, Rikner L, et al. Omeprazole and H2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a meta-analysis. Eur J Gastroenterol Hepatol. 1995;7:467\u201375.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1166_CR50","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1471-230X-2-17","volume":"2","author":"M Salas","year":"2002","unstructured":"Salas M, Ward A, Caro J. Are proton pump inhibitors the first choice for acute treatment of gastric ulcers? A meta analysis of randomized clinical trials. BMC Gastroenterol. 2002;2:17.","journal-title":"BMC Gastroenterol"},{"key":"1166_CR51","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0149-2918(97)80098-7","volume":"19","author":"SR Tunis","year":"1997","unstructured":"Tunis SR, Sheinhait IA, Schmid CH, et al. Lansoprazole compared with histamine2-receptor antagonists in healing gastric ulcers: a meta-analysis. Clin Ther. 1997;19:743\u201357.","journal-title":"Clin Ther"},{"key":"1166_CR52","first-page":"151","volume":"30","author":"L Barbara","year":"1983","unstructured":"Barbara L, Corinaldesi R, Dobrilla G, et al. Ranitidine vs. cimetidine: short-term treatment of gastric ulcer. Hepatogastroenterology. 1983;30:151\u20133.","journal-title":"Hepatogastroenterology"},{"issue":"Suppl 3","key":"1166_CR53","doi-asserted-by":"crossref","first-page":"114","DOI":"10.2165\/00003495-198800353-00020","volume":"35","author":"M Inoue","year":"1988","unstructured":"Inoue M. Clinical studies on the use of roxatidine acetate for the treatment of peptic ulcer in Japan. Drugs. 1988;35(Suppl 3):114\u20139.","journal-title":"Drugs"},{"issue":"Suppl 3","key":"1166_CR54","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2165\/00003495-198800353-00021","volume":"35","author":"G Judmaier","year":"1988","unstructured":"Judmaier G. A comparison of roxatidine acetate and ranitidine in gastric ulcer healing. Drugs. 1988;35(Suppl 3):120\u20136.","journal-title":"Drugs"},{"key":"1166_CR55","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3109\/00365528709094489","volume":"136","author":"R Naccaratto","year":"1987","unstructured":"Naccaratto R, Cremer M, Dammann HG, et al. Nizatidine versus ranitidine in gastric ulcer disease: a European multicentre trial. Scand J Gastroenterol Suppl. 1987;136:71\u20138.","journal-title":"Scand J Gastroenterol Suppl"},{"key":"1166_CR56","first-page":"369","volume":"17","author":"A Miyoshi","year":"1989","unstructured":"Miyoshi A, Matsuo Y, Iwasaki A, et al. Clinical evaluation of ZL-101 (Nizatidine) in the treatment of gastric ulcer: a multicenter double-blind comparative study with cimetidine. Yakuri to Chiryo Suppl. 1989;17:369\u201392 (in Japanese).","journal-title":"Yakuri to Chiryo Suppl"},{"key":"1166_CR57","first-page":"2897","volume":"22","author":"A Miyoshi","year":"1985","unstructured":"Miyoshi A, Taniuchi A, Yoshida Y, et al. Clinical evaluation of TZU-0460 in the treatment of gastric ulcer: a multicenter double-blind comparative study with cimetidine. Shinryo to Shinyaku. 1985;22:2897\u2013918 (in Japanese).","journal-title":"Shinryo to Shinyaku"},{"key":"1166_CR58","first-page":"109","volume":"31","author":"A Miyoshi","year":"1984","unstructured":"Miyoshi A, Taniuchi A, Yahana T, et al. Clinical evaluation of famotidine in the treatment of gastric ulcer: a multicenter double-blind comparative study with cimetidine. Naikahoukan. 1984;31:109\u2013217 (in Japanese).","journal-title":"Naikahoukan"},{"key":"1166_CR59","first-page":"2085","volume":"14","author":"Y Matsuo","year":"1998","unstructured":"Matsuo Y, Miyoshi A, Miwa T, et al. Clinical evaluation of FRG-8813 (Lafutidine) in the treatment of gastric ulcer: a multicenter double-blind comparative study with cimetidine. Rinsyoiyaku. 1998;14:2085\u2013102 (in Japanese).","journal-title":"Rinsyoiyaku"},{"key":"1166_CR60","doi-asserted-by":"crossref","first-page":"806","DOI":"10.3109\/00365528609011121","volume":"21","author":"JJ Gonvers","year":"1986","unstructured":"Gonvers JJ, Realini S, Bretholz A, et al. Gastric ulcer: a double-blind comparison of 100\u00a0mg pirenzepine plus antacid vs. 800\u00a0mg cimetidine plus antacid. Scand J Gastroenterol. 1986;21:806\u20138.","journal-title":"Scand J Gastroenterol"},{"key":"1166_CR61","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1136\/gut.31.7.825","volume":"31","author":"AL Blum","year":"1990","unstructured":"Blum AL, Bethge H, Bode JC, et al. Sucralfate in the treatment and prevention of gastric ulcer: multicentre double blind placebo controlled study. Gut. 1990;31:825\u201330.","journal-title":"Gut"},{"key":"1166_CR62","first-page":"39","volume":"140","author":"H Glise","year":"1987","unstructured":"Glise H, Carling L, Hallerback B, et al. Treatment of peptic ulcers\u2014acid reduction or cytoprotection? Scand J Gastroenterol Suppl. 1987;140:39\u201347.","journal-title":"Scand J Gastroenterol Suppl"},{"key":"1166_CR63","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1136\/gut.27.7.778","volume":"27","author":"B Hallerback","year":"1986","unstructured":"Hallerback B, Anker-Hansen O, Carling L, et al. Short term treatment of gastric ulcer: a comparison of sucralfate and cimetidine. Gut. 1986;27:778\u201383.","journal-title":"Gut"},{"key":"1166_CR64","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/0002-9343(89)90166-6","volume":"86","author":"JM Herrerias-Gutierrez","year":"1989","unstructured":"Herrerias-Gutierrez JM, Pardo L, Segu JL. Sucralfate versus ranitidine in the treatment of gastric ulcer: randomized clinical results in short-term and maintenance therapy. Am J Med. 1989;86:94\u20137.","journal-title":"Am J Med"},{"key":"1166_CR65","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0002-9343(89)90170-8","volume":"86","author":"A Hjortrup","year":"1989","unstructured":"Hjortrup A, Svendsen LB, Beck H, et al. Two daily doses of sucralfate or cimetidine in the healing of gastric ulcer: a comparative randomized study. Am J Med. 1989;86:113\u20135.","journal-title":"Am J Med"},{"key":"1166_CR66","first-page":"49","volume":"83","author":"J Lahtinen","year":"1983","unstructured":"Lahtinen J, Aukee S, Miettinen P, et al. Sucralfate, and cimetidine for gastric ulcer. Scand J Gastroenterol Suppl. 1983;83:49\u201351.","journal-title":"Scand J Gastroenterol Suppl"},{"key":"1166_CR67","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/0002-9343(89)90171-X","volume":"86","author":"JF Rey","year":"1989","unstructured":"Rey JF, Legras B, Verdier A, et al. Comparative study of sucralfate versus cimetidine in the treatment of acute gastroduodenal ulcer: randomized trial with 667 patients. Am J Med. 1989;86:116\u201321.","journal-title":"Am J Med"},{"key":"1166_CR68","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF01297045","volume":"32","author":"LE Svedberg","year":"1987","unstructured":"Svedberg LE, Carling L, Glise H, et al. Short-term treatment of prepyloric ulcer: comparison of sucralfate and cimetidine. Dig Dis Sci. 1987;32:225\u201331.","journal-title":"Dig Dis Sci"},{"key":"1166_CR69","first-page":"233","volume":"34","author":"JJ Gonvers","year":"1987","unstructured":"Gonvers JJ, Aenishanslin W, Backwinkel K, et al. Gastric ulcer: a double blind comparison of 800 mcg misoprostol vs. 300\u00a0mg ranitidine. Hepatogastroenterology. 1987;34:233\u20135.","journal-title":"Hepatogastroenterology"},{"key":"1166_CR70","doi-asserted-by":"crossref","first-page":"178S","DOI":"10.1007\/BF01309406","volume":"30","author":"MJ Shield","year":"1985","unstructured":"Shield MJ. Interim results of a multicenter international comparison of misoprostol and cimetidine in the treatment of out-patients with benign gastric ulcers. Dig Dis Sci. 1985;30:178S\u201384S.","journal-title":"Dig Dis Sci"},{"key":"1166_CR71","doi-asserted-by":"crossref","unstructured":"Echizen H. The first-in-class potassium-competitive acid blocker, vonoprazan fumarate: pharmacokinetic and pharmacodynamic considerations. Clin Pharmacokinet. 2015 [Epub ahead of print].","DOI":"10.1007\/s40262-015-0326-7"},{"key":"1166_CR72","first-page":"2557","volume":"25","author":"T Miyahara","year":"1997","unstructured":"Miyahara T, Katsu K, Yamanaka T, et al. Clinical evaluation of combined therapy using lansoprazole with non-antisecretory agent for peptic ulcer. Yakuri to Chiryo. 1997;25:2557\u201368 (in Japanese).","journal-title":"Yakuri to Chiryo"},{"key":"1166_CR73","first-page":"101","volume":"42","author":"A Miyoshi","year":"1995","unstructured":"Miyoshi A, Miwa T, Nakazawa S, et al. Combined therapy with egualen sodium and cimetidine for patients with gastric ulcer; first article of a report: clinical evaluation of initial treatment; a multicenter controlled study in comparison with cimetidine alone. Naikahoukan. 1995;42:101\u201316 (in Japanese).","journal-title":"Naikahoukan"},{"key":"1166_CR74","first-page":"3015","volume":"76","author":"T Kimura","year":"1988","unstructured":"Kimura T, Yoshida Y, Ichida F, et al. Clinical evaluation of teprenone: a multicenter clinical trial. Shindan to Chiryo. 1988;76:3015\u201328 (in Japanese).","journal-title":"Shindan to Chiryo"},{"key":"1166_CR75","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1046\/j.1440-1746.2003.03093.x","volume":"18","author":"H Murata","year":"2003","unstructured":"Murata H, Kawano S, Tsuji S, et al. Combination therapy of ecabet sodium and cimetidine compared with cimetidine alone for gastric ulcer: prospective randomized multicenter study. J Gastroenterol Hepatol. 2003;18:1029\u201333.","journal-title":"J Gastroenterol Hepatol"},{"key":"1166_CR76","first-page":"661","volume":"7","author":"T Poynard","year":"1995","unstructured":"Poynard T, Lemaire M, Agostini H. Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer. Eur J Gastroenterol Hepatol. 1995;7:661\u20135.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1166_CR77","first-page":"393","volume":"17","author":"A Miyoshi","year":"1989","unstructured":"Miyoshi A, Matsuo Y, Iwasaki A, et al. Clinical evaluation of ZL-101 (Nizatidine) in the treatment of duodenal ulcer: a multicenter double-blind comparative study with cimetidine. Yakuri to Chiryo Suppl. 1989;17:393\u2013415 (in Japanese).","journal-title":"Yakuri to Chiryo Suppl"},{"key":"1166_CR78","first-page":"2919","volume":"22","author":"A Miyoshi","year":"1985","unstructured":"Miyoshi A, Taniuchi A, Yoshida Y, et al. Clinical evaluation of TZU-0460 in the treatment of duodenal ulcer: a multicenter double-blind comparative study with cimetidine. Shinryo to Shinyaku. 1985;22:2919\u201339 (in Japanese).","journal-title":"Shinryo to Shinyaku"},{"key":"1166_CR79","first-page":"2103","volume":"14","author":"Y Matsuo","year":"1998","unstructured":"Matsuo Y, Miyoshi A, Miwa T, et al. Clinical evaluation of FRG-8813 (Lafutidine) in the treatment of duodenal ulcer: a multicenter double-blind comparative study with cimetidine. Rinsyoiyaku. 1998;14:2103\u201319 (in Japanese).","journal-title":"Rinsyoiyaku"},{"key":"1166_CR80","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3109\/00365528509089654","volume":"20","author":"BH Jaup","year":"1985","unstructured":"Jaup BH, Cronstedt J, Dotevall G, et al. Pirenzepine versus cimetidine in duodenal ulcer treatment: a clinical and microbiological study. Scand J Gastroenterol. 1985;20:183\u20138.","journal-title":"Scand J Gastroenterol"},{"issue":"Suppl 1","key":"1166_CR81","first-page":"720","volume":"38","author":"BK Agrawal","year":"1990","unstructured":"Agrawal BK, Prasad RN, Kumar P. A comparative therapeutic trial of sucralfate and ranitidine in initial healing and relapse rate of duodenal ulcer. J Assoc Physicians India. 1990;38(Suppl 1):720\u20132.","journal-title":"J Assoc Physicians India"},{"key":"1166_CR82","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/00004836-199108000-00004","volume":"13","author":"A Archimandritis","year":"1991","unstructured":"Archimandritis A, Charitopoulos N, Diamantis T, et al. Comparison of sucralfate and ranitidine twice daily in duodenal ulcer treatment: a multicenter randomized double-blind study. J Clin Gastroenterol. 1991;13:380\u20133.","journal-title":"J Clin Gastroenterol"},{"key":"1166_CR83","doi-asserted-by":"crossref","first-page":"64S","DOI":"10.1016\/0002-9343(91)90453-5","volume":"91","author":"J Garcia-Paredes","year":"1991","unstructured":"Garcia-Paredes J, Diaz Rubio M, Llenas F, et al. Comparison of sucralfate and ranitidine in the treatment of duodenal ulcers. Am J Med. 1991;91:64S\u20137S.","journal-title":"Am J Med"},{"key":"1166_CR84","first-page":"61","volume":"127","author":"H Glise","year":"1987","unstructured":"Glise H, Carling L, Hallerback B, et al. Treatment of acute duodenal ulcer: a Swedish multicenter study. Scand J Gastroenterol Suppl. 1987;127:61\u20136.","journal-title":"Scand J Gastroenterol Suppl"},{"key":"1166_CR85","first-page":"43","volume":"83","author":"P Pop","year":"1983","unstructured":"Pop P, Nikkels RE, Thys O, et al. Comparison of sucralfate and cimetidine in the treatment of duodenal and gastric ulcers: a multicenter study. Scand J Gastroenterol Suppl. 1983;83:43\u20137.","journal-title":"Scand J Gastroenterol Suppl"},{"key":"1166_CR86","first-page":"793","volume":"14","author":"T Sakita","year":"1986","unstructured":"Sakita T, Nakamura T, Ishikawa M, et al. Clinical evaluation of SC-29333 (Misoprostol) in the treatment of duodenal ulcer: a multicenter double-blind comparative study with cimetidine. Rinsyohyoka. 1986;14:793\u2013826 (in Japanese).","journal-title":"Rinsyohyoka"},{"key":"1166_CR87","first-page":"1001","volume":"24","author":"Aranta recurrence prevention meeting","year":"1987","unstructured":"Aranta recurrence prevention meeting. Combined therapy with aldioxa and cimetidine for patients with peptic ulcer; second article of a report. Shinryo to Shinyaku. 1987;24:1001\u201315 (in Japanese).","journal-title":"Shinryo to Shinyaku"},{"key":"1166_CR88","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1136\/gut.24.9.853","volume":"24","author":"E Hentschel","year":"1983","unstructured":"Hentschel E, Sch\u00fctze K, Weiss W, et al. Effect of cimetidine treatment in the prevention of gastric ulcer relapse: a one year double blind multicentre study. Gut. 1983;24:853\u20136.","journal-title":"Gut"},{"key":"1166_CR89","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0016-5085(83)80235-2","volume":"85","author":"GD Barr","year":"1983","unstructured":"Barr GD, Kang JY, Canalese J, et al. A two-year prospective controlled study of maintenance cimetidine and gastric ulcer. Gastroenterology. 1983;85:100\u20134.","journal-title":"Gastroenterology"},{"issue":"Suppl 83","key":"1166_CR90","first-page":"61","volume":"18","author":"M Classen","year":"1983","unstructured":"Classen M, Bethge H, Brunner G, et al. Effect of sucralfate on peptic ulcer recurrence: a controlled double-blind multicenter study. Scand J Gastroenterol. 1983;18(Suppl 83):61\u20138.","journal-title":"Scand J Gastroenterol"},{"key":"1166_CR91","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1136\/pgmj.60.708.665","volume":"60","author":"JD Kinloch","year":"1984","unstructured":"Kinloch JD, Pearson AJ, Woolf IL, et al. The effect of cimetidine on the maintenance of healing of gastric ulceration. Postgrad Med J. 1984;60:665\u20137.","journal-title":"Postgrad Med J"},{"key":"1166_CR92","doi-asserted-by":"crossref","first-page":"400","DOI":"10.5694\/j.1326-5377.1986.tb112395.x","volume":"145","author":"DW Piper","year":"1986","unstructured":"Piper DW, Pym BM, Toy S, et al. The effect of maintenance cimetidine therapy on the medical, social and economic aspects of patients with chronic gastric ulcers: a placebo-controlled prospective study. Med J Aust. 1986;145:400\u20133.","journal-title":"Med J Aust"},{"key":"1166_CR93","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1136\/gut.28.4.460","volume":"28","author":"R Jorde","year":"1987","unstructured":"Jorde R, Burhol PG, Hansen T. Ranitidine 150\u00a0mg at night in the prevention of gastric ulcer relapse. Gut. 1987;28:460\u20133.","journal-title":"Gut"},{"key":"1166_CR94","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0002-9343(87)90836-9","volume":"83","author":"IN Marks","year":"1987","unstructured":"Marks IN, Girdwood AH, Wright JP, et al. Nocturnal dosage regimen of sucralfate in maintenance treatment of gastric ulcer. Am J Med. 1987;83:95\u20138.","journal-title":"Am J Med"},{"key":"1166_CR95","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJM198409133111101","volume":"311","author":"S Sontag","year":"1984","unstructured":"Sontag S, Graham DY, Belsito A, et al. Cimetidine, cigarette smoking, and recurrence of duodenal ulcer. N Engl J Med. 1984;311:689\u201393.","journal-title":"N Engl J Med"},{"key":"1166_CR96","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1365-2036.1990.tb00473.x","volume":"4","author":"RH Palmer","year":"1990","unstructured":"Palmer RH, Frank WO, Karlstadt R. Maintenance therapy of duodenal ulcer with H2-receptor antagonists\u2014a meta-analysis. Aliment Pharmacol Ther. 1990;4:283\u201394.","journal-title":"Aliment Pharmacol Ther"},{"key":"1166_CR97","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0002-9343(86)90597-8","volume":"81","author":"EC Texter Jr","year":"1986","unstructured":"Texter EC Jr, Navab F, Mantell G, et al. Maintenance therapy of duodenal ulcer with famotidine. A multicenter United States study. Am J Med. 1986;81:25\u201332.","journal-title":"Am J Med"},{"key":"1166_CR98","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1440-1746.1995.tb01055.x","volume":"10","author":"KL Goh","year":"1995","unstructured":"Goh KL, Boonyapisit S, Lai KH, et al. Prevention of duodenal ulcer relapse with omeprazole 20\u00a0mg daily: a randomized double-blind, placebo-controlled study. J Gastroenterol Hepatol. 1995;10:92\u20137.","journal-title":"J Gastroenterol Hepatol"},{"key":"1166_CR99","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/rheumatology\/32.6.474","volume":"32","author":"G Tildesley","year":"1993","unstructured":"Tildesley G, Ehsanullah RS, Wood JR. Ranitidine in the treatment of gastric and duodenal ulcers associated with non-steroidal anti-inflammatory drugs. Br J Rheumatol. 1993;32:474\u20138.","journal-title":"Br J Rheumatol."},{"key":"1166_CR100","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1001\/archinte.1989.00390040017004","volume":"149","author":"S Roth","year":"1989","unstructured":"Roth S, Agrawal N, Mahowald M, et al. Misoprostol heals gastroduodenal injury in patients with rheumatoid arthritis receiving aspirin. Arch Intern Med. 1989;149:775\u20139.","journal-title":"Arch Intern Med"},{"key":"1166_CR101","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/archinte.160.10.1455","volume":"160","author":"NM Agrawal","year":"2000","unstructured":"Agrawal NM, Campbell DR, Safdi MA, et al. Superiority of lansoprazole vs ranitidine in healing nonsteroidal anti-inflammatory drug-associated gastric ulcers: results of a double-blind, randomized, multicenter study. NSAID-Associated Gastric Ulcer Study Group. Arch Intern Med. 2000;160:1455\u201361.","journal-title":"Arch Intern Med"},{"key":"1166_CR102","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJM199803123381105","volume":"338","author":"CJ Hawkey","year":"1998","unstructured":"Hawkey CJ, Karrasch JA, Szczepa\u00f1ski L, et al. Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole vs. Misoprostol for NSAID-induced Ulcer Management(OMNIUM)Group. N Engl J Med. 1998;338:727\u201334.","journal-title":"N Engl J Med"},{"key":"1166_CR103","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1136\/gut.39.1.22","volume":"39","author":"G Bianchi Porro","year":"1996","unstructured":"Bianchi Porro G, Parente F, Imbesi V, et al. Role of Helicobacter pylori in ulcer healing and recurrence of gastric and duodenal ulcers in longterm NSAID users. Response to omeprazole dual therapy. Gut. 1996;39:22\u20136.","journal-title":"Gut"},{"key":"1166_CR104","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(02)07272-0","volume":"359","author":"FK Chan","year":"2002","unstructured":"Chan FK, To KF, Wu JC, et al. Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial. Lancet. 2002;359:9\u201313.","journal-title":"Lancet"},{"key":"1166_CR105","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1111\/j.1365-2036.2005.02444.x","volume":"21","author":"M Vergara","year":"2005","unstructured":"Vergara M, Catalan M, Gisbert JP, et al. Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users. Aliment Pharmacol Ther. 2005;21:1411\u20138.","journal-title":"Aliment Pharmacol Ther"},{"key":"1166_CR106","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1523-5378.2012.00942.x","volume":"17","author":"CL Tang","year":"2012","unstructured":"Tang CL, Ye F, Liu W, et al. Eradication of Helicobacter pylori infection reduces the incidence of peptic ulcer disease in patients using nonsteroidal anti-inflammatory drugs: a meta-analysis. Helicobacter. 2012;17:286\u201396.","journal-title":"Helicobacter"},{"issue":"Suppl 1","key":"1166_CR107","first-page":"S54","volume":"31","author":"M Koch","year":"1999","unstructured":"Koch M. Non-steroidal anti-inflammatory drug gastropathy: clinical results with misoprostol. Ital J Gastroenterol Hepatol. 1999;31(Suppl 1):S54\u201362.","journal-title":"Ital J Gastroenterol Hepatol"},{"key":"1166_CR108","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1056\/NEJM199605303342204","volume":"334","author":"AS Taha","year":"1996","unstructured":"Taha AS, Hudson N, Hawkey CJ, et al. Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs. N Engl J Med. 1996;334:1435\u20139.","journal-title":"N Engl J Med"},{"key":"1166_CR109","doi-asserted-by":"crossref","first-page":"R52","DOI":"10.1186\/ar2207","volume":"9","author":"HE Vonkeman","year":"2007","unstructured":"Vonkeman HE, Fernandes RW, van der Palen J, et al. Proton-pump inhibitors are associated with a reduced risk for bleeding and perforated gastroduodenal ulcers attributable to non-steroidal anti-inflammatory drugs: a nested case-control study. Arthritis Res Ther. 2007;9:R52.","journal-title":"Arthritis Res Ther"},{"key":"1166_CR110","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.clinthera.2004.10.002","volume":"26","author":"JL Goldstein","year":"2004","unstructured":"Goldstein JL, Huang B, Amer F, et al. Ulcer recurrence in high-risk patients receiving nonsteroidal anti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis. Clin Ther. 2004;26:1637\u201343.","journal-title":"Clin Ther"},{"key":"1166_CR111","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S1590-8658(00)80402-8","volume":"32","author":"M Koch","year":"2000","unstructured":"Koch M, Deiz A, Tarquini M, et al. Prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal mucosal injury: risk factors for serious complications. Digest Liver Dis. 2000;32:138\u201351.","journal-title":"Digest Liver Dis"},{"key":"1166_CR112","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1572-0241.2006.00499.x","volume":"101","author":"JM Scheiman","year":"2006","unstructured":"Scheiman JM, Yeomans ND, Talley NJ, et al. Prevention of ulcers by esomeprazole in at high risk patients using non-selective NSAID and COX-2 inhibitors. Am J Gastroenterol. 2006;101:701\u201310.","journal-title":"Am J Gastroenterol"},{"key":"1166_CR113","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1007\/s00535-012-0541-z","volume":"47","author":"K Sugano","year":"2012","unstructured":"Sugano K, Kontani T, Katsuo S, et al. Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term non-steroidal anti-inflammatory drug (NSAID) therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial. J Gastroenterol. 2012;47:540\u201352.","journal-title":"J Gastroenterol"},{"key":"1166_CR114","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/S0140-6736(07)60749-1","volume":"369","author":"FK Chan","year":"2007","unstructured":"Chan FK, Wong VW, Suen BY, et al. Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomised trial. Lancet. 2007;369:1621\u20136.","journal-title":"Lancet"},{"key":"1166_CR115","doi-asserted-by":"crossref","first-page":"4535","DOI":"10.3748\/wjg.14.4535","volume":"14","author":"GS Feng","year":"2008","unstructured":"Feng GS, Ma JL, Wong BC, et al. Celecoxib-related gastroduodenal ulcer and cardiovascular events in a randomized trial for cancer prevention. World J Gastroenterol. 2008;14:4535\u20139.","journal-title":"World J Gastroenterol"},{"key":"1166_CR116","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(99)02332-6","volume":"354","author":"P Emery","year":"1999","unstructured":"Emery P, Zeidler H, Kvien TK, et al. Celecoxib vs. diclofenac in long-term management of rheumatoid arthritis: randomized double-blind comparison. Lancet. 1999;354:2106\u201311.","journal-title":"Lancet"},{"key":"1166_CR117","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.amjmed.2005.04.031","volume":"118","author":"KC Lai","year":"2005","unstructured":"Lai KC, Chu KM, Hui WM, et al. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications. Am J Med. 2005;118:1271\u20138.","journal-title":"Am J Med"},{"key":"1166_CR118","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/apt.12174","volume":"37","author":"C Sakamoto","year":"2013","unstructured":"Sakamoto C, Kawai T, Nakamura S, et al. Comparison of gastroduodenal ulcer incidence in healthy Japanese subjects taking celecoxib or loxoprofen evaluated by endoscopy: a placebo-controlled, double-blind 2-week study. Aliment Pharmacol Ther. 2013;37:346\u201354.","journal-title":"Aliment Pharmacol Ther"},{"key":"1166_CR119","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1136\/bmj.321.7270.1183","volume":"321","author":"S Derry","year":"2000","unstructured":"Derry S, Loke YK. Risk of gastrointestinal haemorrhage with long-term use of aspirin: meta-analysis. BMJ. 2000;321:1183\u20137.","journal-title":"BMJ"},{"key":"1166_CR120","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/ajg.2012.87","volume":"107","author":"CP Liu","year":"2012","unstructured":"Liu CP, Chen WC, Lai KH, et al. Esomeprazole alone compared with esomeprazole plus aspirin for the treatment of aspirin-related peptic ulcers. Am J Gastroenterol. 2012;107:1022\u20139.","journal-title":"Am J Gastroenterol"},{"key":"1166_CR121","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1007\/s00535-013-0839-5","volume":"49","author":"N Uemura","year":"2014","unstructured":"Uemura N, Sugano K, Hiraishi H, et al. The MAGIC Study Group. Risk factor profiles, drug usage, and prevalence of aspirin-associated gastroduodenal injuries among high-risk cardiovascular Japanese patients: the results from the MAGIC study. J Gastroenterol. 2014;49:814\u201324.","journal-title":"J Gastroenterol"},{"key":"1166_CR122","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1136\/hrt.2010.217547","volume":"97","author":"JM Scheiman","year":"2011","unstructured":"Scheiman JM, Devereaux PJ, Herlitz J, et al. Prevention of peptic ulcers with esomeprazole in patients at risk of ulcer development treated with low-dose acetylsalicylic acid: a randomised, controlled trial (OBERON). Heart. 2011;97:797\u2013802.","journal-title":"Heart"},{"key":"1166_CR123","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/ajg.2011.385","volume":"107","author":"FH Ng","year":"2012","unstructured":"Ng FH, Tunggal P, Chu WM, et al. Esomeprazole compared with famotidine in the prevention of upper gastrointestinal bleeding in patients with acute coronary syndrome or myocardial infarction. Am J Gastroenterol. 2012;107:389\u201396.","journal-title":"Am J Gastroenterol"},{"key":"1166_CR124","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0140-6736(09)61246-0","volume":"374","author":"AS Taha","year":"2009","unstructured":"Taha AS, McCloskey C, Prasad R, et al. Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial. Lancet. 2009;374:119\u201325.","journal-title":"Lancet"},{"key":"1166_CR125","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1111\/j.1572-0241.2008.01995.x","volume":"103","author":"N Yeomans","year":"2008","unstructured":"Yeomans N, Lanas A, Labenz J, et al. Efficacy of esomeprazole (20\u00a0mg once daily) for reducing the risk of gastroduodenal ulcers associated with continuous use of low-dose aspirin. Am J Gastroenterol. 2008;103:2465\u201373.","journal-title":"Am J Gastroenterol"},{"key":"1166_CR126","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00228-006-0171-6","volume":"62","author":"C Sakamoto","year":"2006","unstructured":"Sakamoto C, Sugano K, Ota S, et al. Case-control study on the association of upper gastrointestinal bleeding and nonsteroidal anti-inflammatory drugs in Japan. Eur J Clin Pharmacol. 2006;62:765\u201372.","journal-title":"Eur J Clin Pharmacol"},{"key":"1166_CR127","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1001\/archinte.162.19.2197","volume":"162","author":"SM Weisman","year":"2002","unstructured":"Weisman SM, Graham DY. Evaluation of the benefits and risks of low-dose aspirin in the secondary prevention of cardiovascular and cerebrovascular events. Arch Intern Med. 2002;162:2197\u2013202.","journal-title":"Arch Intern Med"},{"key":"1166_CR128","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.cgh.2011.05.020","volume":"9","author":"A Lanas","year":"2011","unstructured":"Lanas A, Wu P, Medin J, Mills EJ. Low doses of acetylsalicylic acid increase risk of gastrointestinal bleeding in a meta-analysis. Clin Gastroenterol Hepatol. 2011;9:762\u20138.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1166_CR129","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa1007964","volume":"363","author":"DL Bhatt","year":"2010","unstructured":"Bhatt DL, Cryer BL, Contant CF, For the COGENT Investigators, et al. Clopidogrel with or without omeprazole in coronary artery disease. N Engl J Med. 2010;363:1909\u201317.","journal-title":"N Engl J Med"},{"key":"1166_CR130","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1046\/j.0306-5251.2001.01476.x","volume":"52","author":"LA Garc\u00eda Rodr\u00edguez","year":"2001","unstructured":"Garc\u00eda Rodr\u00edguez LA, Hern\u00e1ndez-D\u00edaz S, de Abajo FJ. Association between aspirin and upper gastrointestinal complications: systemic review of epidemiologic studies. Br J Clin Pharmacol. 2001;52:563\u201371.","journal-title":"Br J Clin Pharmacol"},{"key":"1166_CR131","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1056\/NEJM200103293441304","volume":"344","author":"FK Chan","year":"2001","unstructured":"Chan FK, Chung SC, Suen BY, et al. Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen. N Engl J Med. 2001;344:967\u201373.","journal-title":"N Engl J Med"},{"key":"1166_CR132","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1056\/NEJMoa012877","volume":"346","author":"KC Lai","year":"2002","unstructured":"Lai KC, Lam SK, Chu KM, et al. Lansoprazole for the prevention of recurrence of ulcer complications from long-term low-dose aspirin use. N Engl J Med. 2002;346:2033\u20138.","journal-title":"N Engl J Med"},{"key":"1166_CR133","first-page":"860","volume":"7","author":"KC Lai","year":"2006","unstructured":"Lai KC, Chu KM, Hui WM, et al. Esomeprazole with aspirin versus clopidogrel for prevention of recurrent gastrointestinal ulcer complications. Clin Gastroenterol Hepatol. 2006;7:860\u20135.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1166_CR134","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa042087","volume":"352","author":"FK Chan","year":"2005","unstructured":"Chan FK, Ching JYL, Hung LCT, et al. Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding. NEJM. 2005;352:238\u201344.","journal-title":"NEJM"},{"key":"1166_CR135","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1053\/j.gastro.2012.12.038","volume":"144","author":"FK Chan","year":"2013","unstructured":"Chan FK, Ching JY, Suen BY, et al. Effects of Helicobacter pylori infection on long-term risk of peptic ulcer bleeding in low-dose aspirin users. Gastroenterology. 2013;144:528\u201335.","journal-title":"Gastroenterology"},{"key":"1166_CR136","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1053\/j.gastro.2009.09.063","volume":"138","author":"FH Ng","year":"2010","unstructured":"Ng FH, Wong SY, Lam KF, et al. Famotidine is inferior to pantoprazole in preventing recurrence of aspirin-related peptic ulcers or erosions. Gastroenterology. 2010;138:82\u20138.","journal-title":"Gastroenterology"},{"key":"1166_CR137","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1007\/s00535-011-0397-7","volume":"46","author":"K Sugano","year":"2011","unstructured":"Sugano K, Matsumoto Y, Itabashi T, et al. Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term low-dose aspirin therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial. J Gastroenterol. 2011;46:724\u201335.","journal-title":"J Gastroenterol"},{"key":"1166_CR138","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1007\/s00535-012-0588-x","volume":"47","author":"T Sanuki","year":"2012","unstructured":"Sanuki T, Fujita T, Kutsumi H, et al. Case Study Group. Rabeprazole reduces the recurrence risk of peptic ulcers associated with low-dose aspirin in patients with cardiovascular or cerebrovascular disease: a prospective randomized active-controlled trial. J Gastroenterol. 2012;47:1186\u201397.","journal-title":"J Gastroenterol"},{"key":"1166_CR139","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1136\/gutjnl-2013-304722","volume":"63","author":"K Sugano","year":"2014","unstructured":"Sugano K, Choi MG, Lin JT, on behalf of the LAVENDER Study Group, et al. Multinational, double-blind, randomised, placebo-controlled, prospective study of esomeprazole in the prevention of recurrent peptic ulcer in low-dose acetylsalicylic acid users: the LAVENDER study. Gut. 2014;63:1061\u20138.","journal-title":"Gut"},{"key":"1166_CR140","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1053\/j.gastro.2004.05.001","volume":"127","author":"L Laine","year":"2004","unstructured":"Laine L, Maller ES, Yu C, et al. Ulcer formation with low-dose enteric-coated aspirin and the effect of COX-2 selective inhibition: a double-blind trial. Gastroenterology. 2004;127:395\u2013402.","journal-title":"Gastroenterology"},{"key":"1166_CR141","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1016\/S0140-6736(07)61909-6","volume":"370","author":"V Strand","year":"2007","unstructured":"Strand V. Are COX-2 inhibitors preferable to non-selective non-steroidal anti-inflammatory drugs in patients with risk of cardiovascular events taking low-dose aspirin? Lancet. 2007;370:2138\u201351.","journal-title":"Lancet"},{"key":"1166_CR142","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1111\/j.1365-2036.2006.02912.x","volume":"23","author":"J Goldstein","year":"2006","unstructured":"Goldstein J, Lowry SC, Lanza FL, et al. The impact of low-dose aspirin on endoscopic gastric and duodenal ulcer rates in users of a non-selective non-steroidal anti-inflammatory drug or a cyclo-oxygenase-2-selective inhibitor. Alm Pharmacol Ter. 2006;23:1489\u201398.","journal-title":"Alm Pharmacol Ter"},{"key":"1166_CR143","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1365-2036.2010.04378.x","volume":"32","author":"JL Goldstein","year":"2010","unstructured":"Goldstein JL, Hochberg MC, Fort JG, et al. Clinical trial: the incidence of NSAID-associated endoscopic gastric ulcers in patients treated with PN 400 (naproxen plus esomeprazole magnesium) vs. enteric-coated naproxen alone. Aliment Pharmacol Ther. 2010;32:401\u201313.","journal-title":"Aliment Pharmacol Ther"},{"key":"1166_CR144","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.cgh.2007.06.009","volume":"5","author":"JL Goldstein","year":"2007","unstructured":"Goldstein JL, Cryer B, Amer F, et al. Celecoxib plus aspirin versus naproxen and lansoprazole plus aspirin: a randomized, double-blind, endoscopic trial. Clinical Gastroenterol Hepatol. 2007;5:1167\u201374.","journal-title":"Clinical Gastroenterol Hepatol"},{"issue":"Suppl 2","key":"1166_CR145","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1046\/j.1365-2036.2001.00114.x","volume":"15","author":"JW Freston","year":"2001","unstructured":"Freston JW. Review article: role of proton pump inhibitors in non-H. pylori-related ulcers. Aliment Pharmacol Ther. 2001;15(Suppl 2):2\u20135.","journal-title":"Aliment Pharmacol Ther"},{"key":"1166_CR146","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1053\/j.gastro.2009.05.006","volume":"37","author":"GL Wong","year":"2009","unstructured":"Wong GL, Wong VW, Chan Y, et al. High incidence of mortality and recurrent bleeding in patients with Helicobacter pylori-negative idiopathic bleeding ulcers. Gastroenterology. 2009;37:525\u201331.","journal-title":"Gastroenterology"},{"key":"1166_CR147","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.cgh.2012.06.012","volume":"10","author":"GL Wong","year":"2012","unstructured":"Wong GL, Au KW, Lo AO, et al. Gastroprotective therapy does not improve outcomes of patients with Helicobacter pylori-negative idiopathic bleeding ulcers. Clin Gastroenterol Hepatol. 2012;10:1124\u20139.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1166_CR148","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1056\/NEJM198904133201504","volume":"320","author":"TJ Crofts","year":"1989","unstructured":"Crofts TJ, Park KG, Steele RJ, et al. A random trial of nonoperative treatment for perforated peptic ulcer. N Engle Med. 1989;320:970\u20133.","journal-title":"N Engle Med"},{"key":"1166_CR149","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1136\/bmj.288.6426.1277","volume":"288","author":"DL Morris","year":"1984","unstructured":"Morris DL, Hawker PC, Brearley S, et al. Optimal timing of operation for bleeding peptic ulcer: prospective randomized trial. Br Med J (Clin Res Ed). 1984;288:1277\u201380.","journal-title":"Br Med J (Clin Res Ed)"},{"key":"1166_CR150","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1007\/s00268-009-9953-1","volume":"33","author":"D Guinier","year":"2009","unstructured":"Guinier D, Destrumelle N, Denue PO, et al. Technique of antroduodenectomy without ulcer excision as a safe alternative treatment for bleeding chronic duodenal ulcers. World J Surg. 2009;33:1010\u20134.","journal-title":"World J Surg"},{"key":"1166_CR151","first-page":"654","volume":"180","author":"K Dittrich","year":"1995","unstructured":"Dittrich K, Blaunensteiner W, Schrutka-Kolbl C, et al. Highly selective vagotomy plus Jaboulay: a possible alternative in patients with benign stenosis secondary to duodenal ulceration. J Am Coll Surg. 1995;180:654\u20138.","journal-title":"J Am Coll Surg"},{"key":"1166_CR152","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1523-5378.2011.00928.x","volume":"17","author":"P Tomtitchong","year":"2012","unstructured":"Tomtitchong P, Sirlbumrungwong B, Vilaichone RK, et al. Systematic review and meta-analysis: Helicobacter pylori eradication therapy after simple closure of perforated duodenal ulcer. Helicobacter. 2012;17:148\u201352.","journal-title":"Helicobacter"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-016-1166-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00535-016-1166-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-016-1166-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T11:04:36Z","timestamp":1718363076000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00535-016-1166-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,15]]},"references-count":152,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["1166"],"URL":"https:\/\/doi.org\/10.1007\/s00535-016-1166-4","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,15]]}}}